Seeking Alpha

Johnson & Johnson (JNJ) says it will buy Swiss medical-device maker Synthes for $21.3B (1/3...

Johnson & Johnson (JNJ) says it will buy Swiss medical-device maker Synthes for $21.3B (1/3 cash, 2/3 stock - a 22% premium), giving it a commanding lead in the global market for surgical devices used to treat bone fractures and trauma. It's unclear whether Synthes' shareholders will be satisfied with the price.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector